{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:38:15Z","timestamp":1794998295176,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA248430, CA217648, CA123088, CA099985, CA193136, CA152470"],"award-info":[{"award-number":["CA248430, CA217648, CA123088, CA099985, CA193136, CA152470"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA233487"],"award-info":[{"award-number":["CA233487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["CA240515"],"award-info":[{"award-number":["CA240515"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["S10OD020053"],"award-info":[{"award-number":["S10OD020053"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1UM1HG006508"],"award-info":[{"award-number":["1UM1HG006508"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA216440"],"award-info":[{"award-number":["U01CA216440"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011354","name":"U-M | Comprehensive Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["P30CA46592"],"award-info":[{"award-number":["P30CA46592"]}],"id":[{"id":"10.13039\/100011354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41591-020-1131-x","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:07:03Z","timestamp":1609762023000},"page":"152-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":995,"title":["Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination"],"prefix":"10.1038","volume":"27","author":[{"given":"Jiali","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-7118","authenticated-orcid":false,"given":"Michael D.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1341-382X","authenticated-orcid":false,"given":"Yilun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-9774","authenticated-orcid":false,"given":"Sara N.","family":"Journey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Eun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Monem","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Waninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6349-2431","authenticated-orcid":false,"given":"Zoey","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6023-1132","authenticated-orcid":false,"given":"Issam","family":"El Naqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9599-9907","authenticated-orcid":false,"given":"Yingjie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alangoya","family":"Tezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Skvarce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan K.","family":"Achar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merna","family":"Sitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathiya P.","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Szeliga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin A.","family":"Schonewolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-2533","authenticated-orcid":false,"given":"Ilona","family":"Kryczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-4796","authenticated-orcid":false,"given":"Fei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-3415","authenticated-orcid":false,"given":"Arul M.","family":"Chinnaiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Cieslik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajjai","family":"Alva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-3549","authenticated-orcid":false,"given":"Weiping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nrc1886","volume":"6","author":"P Mehlen","year":"2006","unstructured":"Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nat. Rev. Cancer 6, 449\u2013458 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1131_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","volume":"132","author":"G Disibio","year":"2008","unstructured":"Disibio, G. & French, S. W. Metastatic patterns of cancers: results from a large autopsy study. Arch. Pathol. Lab. Med. 132, 931\u2013939 (2008).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"1131_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/cmi.2013.7","volume":"10","author":"F Li","year":"2013","unstructured":"Li, F. & Tian, Z. The liver works as a school to educate regulatory immune cells. Cell. Mol. Immunol. 10, 292\u2013302 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"1131_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","volume":"66","author":"DG Doherty","year":"2016","unstructured":"Doherty, D. G. Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J. Autoimmun. 66, 60\u201375 (2016).","journal-title":"J. Autoimmun."},{"key":"1131_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nri981","volume":"3","author":"IN Crispe","year":"2003","unstructured":"Crispe, I. N. Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3, 51\u201362 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"1131_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-0528.2002.017412.x","volume":"174","author":"IN Crispe","year":"2000","unstructured":"Crispe, I. N., Dao, T., Klugewitz, K., Mehal, W. Z. & Metz, D. P. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 174, 47\u201362 (2000).","journal-title":"Immunol. Rev."},{"key":"1131_CR7","doi-asserted-by":"publisher","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","volume":"8","author":"W Zou","year":"2016","unstructured":"Zou, W., Wolchok, J. D. & Chen, L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci. Transl. Med. 8, 328rv4 (2016).","journal-title":"Sci. Transl. Med."},{"key":"1131_CR8","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1131_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1172\/JCI96113","volume":"128","author":"H Lin","year":"2018","unstructured":"Lin, H. et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade\u2013mediated tumor regression. J. Clin. Invest. 128, 805\u2013815 (2018).","journal-title":"J. Clin. Invest."},{"key":"1131_CR10","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei, S. C., Duffy, C. R. & Allison, J. P. Fundamental mechanisms of immune checkpoint blockade therapy. Cancer Discov. 8, 1069\u20131086 (2018).","journal-title":"Cancer Discov."},{"key":"1131_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nm863","volume":"9","author":"TJ Curiel","year":"2003","unstructured":"Curiel, T. J., Wei, S., Dong, H., Alvarez, X. & Cheng, P. Blockade of B7-H1 improves myeloid dendritic cell\u2013mediated antitumor immunity. Nat. Med. 9, 562\u2013567 (2003).","journal-title":"Nat. Med."},{"key":"1131_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"1131_CR13","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.cell.2019.10.029","volume":"179","author":"S Jiao","year":"2019","unstructured":"Jiao, S. et al. Differences in tumor microenvironment dictate T helper lineage polarization and response to immune checkpoint therapy. Cell 179, e13 (2019).","journal-title":"Cell"},{"key":"1131_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrc.2017.117","volume":"18","author":"S Spranger","year":"2018","unstructured":"Spranger, S. & Gajewski, T. F. Impact of oncogenic pathways on evasion of antitumour immune responses. Nat. Rev. Cancer 18, 139\u2013147 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"1131_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer\u2013immune set point. Nature 541, 321 (2017).","journal-title":"Nature"},{"key":"1131_CR16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","volume":"24","author":"SC Formenti","year":"2018","unstructured":"Formenti, S. C. et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat. Med. 24, 1845\u20131851 (2018).","journal-title":"Nat. Med."},{"key":"1131_CR17","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1001\/jamaoncol.2019.1478","volume":"5","author":"WS Theelen","year":"2019","unstructured":"Theelen, W. S. et al. Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non\u2013small cell lung cancer: results of the PEMBRO-RT phase 2 randomized clinical trial. JAMA Oncol. 5, 1276\u20131282 (2019).","journal-title":"JAMA Oncol."},{"key":"1131_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/2326-6066.CIR-13-0115","volume":"1","author":"EB Golden","year":"2013","unstructured":"Golden, E. B., Demaria, S., Schiff, P. B., Chachoua, A. & Formenti, S. C. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol. Res 1, 365\u2013372 (2013).","journal-title":"Cancer Immunol. Res"},{"key":"1131_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","volume":"520","author":"C Twyman-Saint Victor","year":"2015","unstructured":"Twyman-Saint Victor, C. et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520, 373\u2013377 (2015).","journal-title":"Nature"},{"key":"1131_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15618","volume":"8","author":"C Vanpouille-Box","year":"2017","unstructured":"Vanpouille-Box, C. et al. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nat. Commun. 8, 15618 (2017).","journal-title":"Nat. Commun."},{"key":"1131_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1172\/JCI67313","volume":"124","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. Irradiation and anti\u2013PD-L1 treatment synergistically promote antitumor immunity in mice. J. Clin. Invest. 124, 687\u2013695 (2014).","journal-title":"J. Clin. Invest."},{"key":"1131_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60\u201365 (2017).","journal-title":"Nature"},{"key":"1131_CR23","doi-asserted-by":"publisher","first-page":"e126908","DOI":"10.1172\/jci.insight.126908","volume":"4","author":"M Yarchoan","year":"2019","unstructured":"Yarchoan, M. et al. PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers. JCI Insight 4, e126908 (2019).","journal-title":"JCI Insight"},{"key":"1131_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CMR.0000000000000520","volume":"29","author":"F Petrelli","year":"2019","unstructured":"Petrelli, F. et al. Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Res. 29, 1 (2019).","journal-title":"Melanoma Res."},{"key":"1131_CR25","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1172\/JCI96061","volume":"128","author":"H Tang","year":"2018","unstructured":"Tang, H. et al. PD-L1 on host cells is essential for PD-L1 blockade\u2013mediated tumor regression. J. Clin. Invest. 128, 580\u2013588 (2018).","journal-title":"J. Clin. Invest."},{"key":"1131_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen, D. S. & Mellman, I. Oncology meets immunology: the cancer-immunity cycle. Immunity 39, 1\u201310 (2013).","journal-title":"Immunity"},{"key":"1131_CR27","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.4049\/jimmunol.172.9.5222","volume":"172","author":"B John","year":"2004","unstructured":"John, B. & Crispe, I. N. Passive and active mechanisms trap activated CD8+ T cells in the liver. J. Immunol. 172, 5222\u20135229 (2004).","journal-title":"J. Immunol."},{"key":"1131_CR28","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","volume":"5","author":"SL Topalian","year":"2019","unstructured":"Topalian, S. L. et al. Five-year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non\u2013small cell lung cancer treated with nivolumab. JAMA Oncol. 5, 1411\u20131420 (2019).","journal-title":"JAMA Oncol."},{"key":"1131_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson, D. R. et al. Integrative clinical genomics of metastatic cancer. Nature 548, 297\u2013303 (2017).","journal-title":"Nature"},{"key":"1131_CR30","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg, J. E. et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet 387, 1909\u20131920 (2016).","journal-title":"Lancet"},{"key":"1131_CR31","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00262-015-1736-y","volume":"64","author":"J Medina-Echeverz","year":"2015","unstructured":"Medina-Echeverz, J., Eggert, T., Han, M. & Greten, T. F. Hepatic myeloid-derived suppressor cells in cancer. Cancer Immunol. Immunother. 64, 931\u2013940 (2015).","journal-title":"Cancer Immunol. Immunother."},{"key":"1131_CR32","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.cmet.2018.04.022","volume":"28","author":"W Li","year":"2018","unstructured":"Li, W. et al. Aerobic glycolysis controls myeloid-derived suppressor cells and tumor immunity via a specific CEBPB Isoform in triple-negative breast cancer. Cell Metab. 28, e6 (2018).","journal-title":"Cell Metab."},{"key":"1131_CR33","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.cell.2020.03.048","volume":"181","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, e29 (2020).","journal-title":"Cell"},{"key":"1131_CR34","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.4049\/jimmunol.167.10.5583","volume":"167","author":"M Saio","year":"2001","unstructured":"Saio, M., Radoja, S., Marino, M. & Frey, A. B. Tumor-infiltrating macrophages induce apoptosis in activated CD8+ T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J. Immunol. 167, 5583\u20135593 (2001).","journal-title":"J. Immunol."},{"key":"1131_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00262-018-2269-y","volume":"68","author":"J Zhu","year":"2019","unstructured":"Zhu, J., Petit, P.-F. & Van den Eynde, B. J. Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism. Cancer Immunol. Immunother. 68, 835\u2013847 (2019).","journal-title":"Cancer Immunol. Immunother."},{"key":"1131_CR36","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.3389\/fimmu.2019.02694","volume":"10","author":"C Bl\u00e9riot","year":"2019","unstructured":"Bl\u00e9riot, C. & Ginhoux, F. Understanding the heterogeneity of resident liver macrophages. Front. Immunol. 10, 2694 (2019).","journal-title":"Front. Immunol."},{"key":"1131_CR37","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2016.08.024","volume":"151","author":"BA David","year":"2016","unstructured":"David, B. A. et al. Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice. Gastroenterology 151, 1176\u20131191 (2016).","journal-title":"Gastroenterology"},{"key":"1131_CR38","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ijrobp.2017.12.014","volume":"100","author":"WC Jackson","year":"2018","unstructured":"Jackson, W. C. et al. Comparison of stereotactic body radiation therapy and radiofrequency ablation in the treatment of intrahepatic metastases. Int. J. Radiat. Oncol.*Biol.*Phys. 100, 950\u2013958 (2018).","journal-title":"Int. J. Radiat. Oncol.*Biol.*Phys."},{"key":"1131_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature15520","volume":"527","author":"D Peng","year":"2015","unstructured":"Peng, D. et al. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature 527, 249\u2013253 (2015).","journal-title":"Nature"},{"key":"1131_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1158\/2326-6066.CIR-16-0325","volume":"5","author":"PC Tumeh","year":"2017","unstructured":"Tumeh, P. C. et al. Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol. Res 5, 417\u2013424 (2017).","journal-title":"Cancer Immunol. Res"},{"key":"1131_CR41","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/hep.25777","volume":"56","author":"H Li","year":"2012","unstructured":"Li, H. et al. Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 56, 1342\u20131351 (2012).","journal-title":"Hepatology"},{"key":"1131_CR42","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1084\/jem.20151218","volume":"213","author":"Z Zeng","year":"2016","unstructured":"Zeng, Z. et al. Interferon-\u03b3 facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance. J. Exp. Med. 213, 1079\u20131093 (2016).","journal-title":"J. Exp. Med."},{"key":"1131_CR43","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/82161","volume":"6","author":"A Limmer","year":"2000","unstructured":"Limmer, A. et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6, 1348\u20131354 (2000).","journal-title":"Nat. Med."},{"key":"1131_CR44","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/hep.21378","volume":"44","author":"A Warren","year":"2006","unstructured":"Warren, A. et al. T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44, 1182\u20131190 (2006).","journal-title":"Hepatology"},{"key":"1131_CR45","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","volume":"29","author":"A Goubier","year":"2008","unstructured":"Goubier, A. et al. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29, 464\u2013475 (2008).","journal-title":"Immunity"},{"key":"1131_CR46","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma, C. et al. Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360, eaan5931 (2018).","journal-title":"Science"},{"key":"1131_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/cmi.2015.112","volume":"13","author":"AK Horst","year":"2016","unstructured":"Horst, A. K., Neumann, K., Diehl, L. & Tiegs, G. Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. Cell. Mol. Immunol. 13, 277\u2013292 (2016).","journal-title":"Cell. Mol. Immunol."},{"key":"1131_CR48","doi-asserted-by":"publisher","first-page":"eaba0759","DOI":"10.1126\/sciimmunol.aba0759","volume":"5","author":"JC Lee","year":"2020","unstructured":"Lee, J. C. et al. Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Sci. Immunol. 5, eaba0759 (2020).","journal-title":"Sci. Immunol."},{"key":"1131_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S2213-2600(19)30084-0","volume":"7","author":"M Reck","year":"2019","unstructured":"Reck, M. et al. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. Lancet Respir. Med 7, 387\u2013401 (2019).","journal-title":"Lancet Respir. Med"},{"key":"1131_CR50","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang, X. et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Disco. 9, 1673\u20131685 (2019).","journal-title":"Cancer Disco."},{"key":"1131_CR51","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1158\/2326-6066.CIR-18-0793","volume":"7","author":"JW Welsh","year":"2019","unstructured":"Welsh, J. W. et al. Phase II trial of Ipilimumab with stereotactic radiation therapy for metastatic disease: outcomes, toxicities, and low-dose radiation-related abscopal responses. Cancer Immunol. Res. 7, 1903\u20131909 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1131_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein, A. N., Brekken, R. A. & Maitra, A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat. Rev. Gastroenterol. Hepatol. 17, 487\u2013505 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1131_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.adro.2016.10.001","volume":"1","author":"CS Mayo","year":"2016","unstructured":"Mayo, C. S. et al. The big data effort in radiation oncology: Data mining or data farming? Adv. Radiat. Oncol. 1, 260\u2013271 (2016).","journal-title":"Adv. Radiat. Oncol."},{"key":"1131_CR54","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-19-0761","volume":"79","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy. Cancer Res. 79, 3940\u20133951 (2019).","journal-title":"Cancer Res."},{"key":"1131_CR55","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4049\/jimmunol.152.1.106","volume":"152","author":"AJ Sijts","year":"1994","unstructured":"Sijts, A. J., Ossendorp, F. & Mengede, E. A. Immunodominant mink cell focus-inducing murine leukemia virus (MuLV)-encoded CTL epitope, identified by its MHC class I-binding motif, explains MuLV specificity of MCF-directed cytotoxic T lymphocytes. J. Immunol. 152, 106\u2013116 (1994).","journal-title":"J. Immunol."},{"key":"1131_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaut.2017.08.005","volume":"84","author":"J Yu","year":"2017","unstructured":"Yu, J. et al. The differential organogenesis and functionality of two liver-draining lymph nodes in mice. J. Autoimmun. 84, 109\u2013121 (2017).","journal-title":"J. Autoimmun."},{"key":"1131_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/cmi.2012.59","volume":"10","author":"M Zheng","year":"2013","unstructured":"Zheng, M., Yu, J. & Tian, Z. Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV. Cell. Mol. Immunol. 10, 143\u2013150 (2013).","journal-title":"Cell. Mol. Immunol."},{"key":"1131_CR58","doi-asserted-by":"publisher","first-page":"e127291","DOI":"10.1172\/jci.insight.127291","volume":"4","author":"AC Billi","year":"2019","unstructured":"Billi, A. C. et al. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. JCI Insight 4, e127291 (2019).","journal-title":"JCI Insight"},{"key":"1131_CR59","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1131_CR60","doi-asserted-by":"publisher","first-page":"e126556","DOI":"10.1172\/jci.insight.126556","volume":"4","author":"KJ Mould","year":"2019","unstructured":"Mould, K. J., Jackson, N. D., Henson, P. M., Seibold, M. & Janssen, W. J. Single cell RNA sequencing identifies unique inflammatory airspace macrophage subsets. JCI Insight 4, e126556 (2019).","journal-title":"JCI Insight"},{"key":"1131_CR61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1131_CR62","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/ni.3445","volume":"17","author":"DF Dwyer","year":"2016","unstructured":"Dwyer, D. F., Barrett, N. A. & Austen, K. F., Immunological Genome Project Consortium. Expression profiling of constitutive mast cells reveals a unique identity within the immune system. Nat. Immunol. 17, 878\u2013887 (2016).","journal-title":"Nat. Immunol."},{"key":"1131_CR63","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1172\/JCI66381","volume":"123","author":"H Peng","year":"2013","unstructured":"Peng, H. et al. Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J. Clin. Invest. 123, 1444\u20131456 (2013).","journal-title":"J. Clin. Invest."},{"key":"1131_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/rssb.12027","volume":"76","author":"K Imai","year":"2014","unstructured":"Imai, K. & Ratkovic, M. Covariate balancing propensity score. J. R. Stat. Soc. Ser. B Stat. Methodol. 76, 243\u2013263 (2014).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1131-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T20:03:36Z","timestamp":1674763416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1131-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1038\/s41591-020-1131-x","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"22 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.Y., M.D.G., S.L., Y.S., S.N.J., J.E.C., S.M.R., J.J.W., X.L., Z.C., J.Z., Y.B., L.J., A.T., J.S., R.K.A., M.S., B.S.R., F.S., S.P.N., X.C., S.W., W.S., L.V., C.M., M.A.M., C.A.S., K.C., I.K., V.T.M., T.S.L., N.R., F.W., A.M.C. and M.C. report no conflicts. A.Q. has research funding from Merck and Clovis. I.E.N. serves as a consultant for Endectra. A.A. serves as a consultant for Merck, AstraZeneca, Bristol-Myers Squibb and Pfizer\/EMD Serono. A.A. receives research funding through the University of Michigan from Merck, Genentech, Prometheus Laboratories, Mirati Therapeutics, Roche, Bayer, Progenics, Astellas Pharma, Arcus Biosciences, AstraZeneca, Bristol-Myers Squibb and Clovis Oncology. C.D.L. serves as a consultant for Immunocore. C.D.L receives travel, accommodations and expenses from Bristol-Myers Squibb and Immunocore. C.D.L. receives research funding from Bristol-Myers Squibb, Merck, Novartis and Dynavax. W.Z. has served as a scientific advisor for Cstone, Oncopia and Hengenix.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}